About Huatai United Securities Co., Ltd
Verification opinions on closing some projects invested with raised funds and permanently replenishing the surplus raised funds with working capital
Huatai United Securities Co., Ltd. (hereinafter referred to as “Huatai United Securities” or “sponsor”) as the sponsor of Wuxi Apptec Co.Ltd(603259) (hereinafter referred to as ” Wuxi Apptec Co.Ltd(603259) ” or “company”) initial public offering of shares in 2018 and non-public offering of shares in 2020, in accordance with the administrative measures for securities issuance and listing recommendation business The guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the stock listing rules of Shanghai Stock Exchange and the guidelines for the self discipline supervision of listed companies of Shanghai Stock Exchange No. 1 – standardized operation and other relevant provisions have carefully verified the closure of Wuxi Apptec Co.Ltd(603259) some raised and invested projects and the permanent supplement of surplus raised funds to working capital, The verification and opinions are as follows: I. Basic information of raised funds
(I) funds raised from initial public offering of a shares
With the approval of the reply on approving Wuxi Apptec Co.Ltd(603259) initial public offering (zjxk [2018] No. 678) of China Securities Regulatory Commission (hereinafter referred to as “CSRC”), the company publicly issued 104198556 ordinary shares (A shares) in Shanghai Stock Exchange (hereinafter referred to as “Shanghai Stock Exchange”), with an issue price of 21.60 yuan per share, The total amount of funds raised from stock issuance is RMB 225068880960. After deducting the issuance expenses of RMB 12040340960, the actual net amount of funds raised is RMB 213028540000. The actual amount received is RMB 216066125722, including other issuance expenses that have not been transferred at that time, including RMB 3037585722 (including other issuance expenses that have been paid from the company’s own capital account in the early stage, RMB 1251841465, and other issuance expenses that have not been paid, RMB 1785744257). All the above-mentioned funds have been received on May 2, 2018, verified by Deloitte Touche Tohmatsu (special general partnership) and issued the capital verification report DSB (y) Zi (18) No. 00197.
As of December 31, 2021, the company has used a total of 149072241709 yuan of raised funds. The balance of unused raised funds is 74896665936 yuan, including 22000000000 lines (including the interest income and wealth management income generated by raised funds, and the net amount after deducting bank charges and others is 10940367645 yuan).
As of December 31, 2021, the closing balance of the bank account of the raised funds related to the initial public offering of A-Shares of the company amounted to RMB 52896665936. The specific deposit conditions are as follows:
Unit: RMB
Name of deposit bank name of deposit company name of account opening account number funds to May 2, 2018 initial deposit amount to December 31, 2021 deposit balance
Ping An Bank Co.Ltd(000001) Co., Ltd. 15062018041
Company Shanghai branch business company 800564000 Ping An Bank Co.Ltd(000001) 65538614 Department
China Merchants Bank Co.Ltd(600036) Co., Ltd. 51090204101
Shanghai pilot free trade company 08022018200000 Ping An Bank Co.Ltd(000001) 1061086 District branch business department may, 2014
Bank Of Communications Co.Ltd(601328) Co., Ltd. 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 012
Wuxi hefukou branch 801803089166946145722638397304
Shanghai Pudong Development Bank 98460078801
Baoshan Branch of Co., Ltd. 7 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 617271998000043590070433 Shanghai Pudong Development Bank Suzhou yaomingkang 98460078801
Baoshan de new drug development Co., Ltd. 2 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 93 – 4439764312 sub branch Co., Ltd
Ping An Bank Co.Ltd(000001) Co., Ltd. Tianjin yaomingkang 150 Beijing Centergate Technologies (Holding) Co.Ltd(000931) 77
Tianjin Binhai sub branch de new drug development 419 not applicable – 4051571260 Co., Ltd
China Merchants Bank Co.Ltd(600036) Co., Ltd. Shanghai yaomingkang 51090204731
Shanghai free trade experimental de new drug development 0103 – 262927 District branch business department Co., Ltd
Total 21606612572252896665936
(II) funds raised from non-public offering of A-Shares in 2020
With the approval of the reply on approving Wuxi Apptec Co.Ltd(603259) non-public Development Bank shares (zjxk [2020] No. 1828) issued by the CSRC, the company is approved to issue no more than 105000000 new shares in non-public, with a par value of RMB 1.00 per share.
The company’s non-public offering of 62690290 RMB ordinary shares at an issue price of 104.13 yuan per share. The total amount of funds raised from stock issuance is 652793989770 yuan. After deducting the issuance expenses of RMB 6669361226 (excluding tax), the net amount of actually raised funds is RMB 646124628544. After deducting the deductible VAT input tax of RMB 400161674 from the issuance expenses of this non-public offering and adding back the other issuance expenses of RMB 867980000 (including tax) that have not been transferred, the actual amount received is RMB 646592446870. The above actually raised funds of RMB 646592446870 have all arrived on September 8, 2020, and have been verified by Deloitte Huayong Certified Public Accountants (special general partnership) and issued a capital verification report of DSB (y) Zi (20) No. 00517.
As of December 31, 2021, the company has accumulated 519262118166 yuan of raised funds. The balance of unused raised funds is 136213395195 yuan (including interest income and wealth management income generated by raised funds, deducting bank charges and others is 9350884817 yuan).
As of December 31, 2021, the ending balance of the bank accounts of the company and its subsidiaries related to the funds raised from the non-public offering of A-Shares in 2020 totaled 136213395195 yuan. The specific deposit conditions are as follows:
Unit: RMB
Name of deposit bank account number of deposit company arrival of funds September 8, 2020 name time December 2021 initial deposit amount 31 deposit balance
Bank Of Communications Co.Ltd(601328) share ownership
Wuxi Helong Company Limited 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 013736280 Ping An Bank Co.Ltd(000001) 1264789489kou sub branch 000394273
Shanghai Pudong Development Bank
Bank Co., Ltd. 984600788019491760 Shenzhen Fountain Corporation(000005) 502469823 Baoshan sub branch 00 Ningxia Qinglong Pipes Industry Group Co.Ltd(002457)
Bank Of Communications Co.Ltd(601328) share ownership
Wuxi Hedong company 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 013660640 Shenzhen Quanxinhao Co.Ltd(000007) 15350260kou sub branch 000395171
Bank Of Communications Co.Ltd(601328) shares will be held in September 2020
Wuxi Hedong Company Limited 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 0131789260 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 5662172105kou sub branch 000395247 August 8
Shanghai Pudong Development Bank
Bank Co., Ltd. 984600788017300000 Ping An Bank Co.Ltd(000001) 6696289381 Baoshan sub branch 00 Shandong Yisheng Livestock & Poultry Breeding Co.Ltd(002458)
Shanghai Pudong Development Bank
Bank Co., Ltd. 984600788015 Shanghai Pudong Development Bank Co.Ltd(600000) China Vanke Co.Ltd(000002) 3179732149 Baoshan sub branch 00 Ja Solar Technology Co.Ltd(002459)
Shanghai Pudong Development Bank
Bank Co., Ltd. 984600788010188798446870778921326 Baoshan sub branch 00 Ganfeng Lithium Co.Ltd(002460)
China Merchants Bank Co.Ltd(600036) shares are owned by Wuxi Hequan
Pharmaceutical Co., Ltd. 5109 Shandong Wit Dyne Health Co.Ltd(000915) 10 not applicable – 802792570 Wuxi Branch 956
China Agricultural Bank Of China Limited(601288) shares Shanghai Hequan
Shanghai Pharmaceutical Co., Ltd. 038576 Tangshan Jidong Cement Co.Ltd(000401) – 6230120527
Jinshan sub branch Co., Ltd. 09608
China China Minsheng Banking Corp.Ltd(600016) shares Changzhou Hequan
Shanghai Pharmaceutical Co., Ltd. 632402943 – 6112558619
Branch Company
China Merchants Bank Co.Ltd(600036) shares are owned by Changzhou Hequan
Pharmaceutical Co., Ltd. 121936945710 – 9391285755
Shanghai Branch Company Limited 590
Shanghai Pudong Development Bank Shanghai Hequan
Pharmaceutical research and Development Co., Ltd. 984600788012 – 727491279
Baoshan sub branch Co., Ltd. Shenzhen Tellus Holding Co.Ltd(000025) 28
China China Construction Bank Corporation(601939) shares Shanghai Yaoming
Shanghai Kant new drug Co., Ltd. 310501100579 – 9149421912
Pilot Free Trade Zone Branch Development Co., Ltd. Shenzhen Overseas Chinese Town Co.Ltd(000069) 37
company
Total 646592446870136213395195
2、 Actual use of funds collected
(I) use of funds raised from initial public offering of a shares
As of December 31, 2021, the company has used the funds raised from the initial public offering of A-Shares in RMB
1490722400 yuan, the specific use is as follows:
